Catherine Szyman - Edwards Lifesciences Insider

EW -- USA Stock  

USD 151.47  2.47  1.66%

  President
Ms. Catherine M. Szyman was Corporationrationrate Vice President, Critical Care of Edwards Lifesciences Corporationrationration since January 2015. Prior to 2015, she was employed for more than 20 years at Medtronic, LLC, where she served as its Senior Vice President and President of Medtronics global diabetes business from 2009 to 2014, overseeing research, development, operations, sales and marketing for Medtronics insulin infusion pumps and continuous glucose monitoring systems. Prior to that, she held a variety of leadership roles at Medtronic, including Senior Vice President of Corporationrationrate Strategy and Business Development, General Manager of Endovascular Innovations and Vice President of Finance for the Cardiovascular Business
Age: 50  President Since 2015      
949-250-2500  http://www.edwards.com
Szyman previously served on the Boards of Tornier, Inspire Medical Systems, and the California Healthcare Institute.

Catherine Szyman Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 11.47 % which means that for every $100 of asset it generated profit of $11.47. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 21.51 % which means that it produced $21.51 on every 100 dollars invested by current stockholders.
The company reports 1.19 B of total liabilities with total debt to equity ratio (D/E) of 37.7 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 2.23 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Found 13 records

PRESIDENT Since

Stephen OklandSecond Sight Medical Products
2018
Thomas GephartDynatronics Corporation
2016
Peter GearyEncision
2017
Martin ShirleyDigirad Corporation
2016
Frank VandeputteSecond Sight Medical Products
2017
Brian BakerDynatronics Corporation
2018
Virgil LottDigirad Corporation
N/A
Douglas SampsonDynatronics Corporation
2009
Robert CardonDynatronics Corporation
2007
Brad GreathouseEncision
2014
Steven OklandSecond Sight Medical Products
2016
David JacquesSecond Sight Medical Products
2017
Anthony MosesSecond Sight Medical Products
2015

Entity Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and traded on BATS Exchange. It employs 12200 people.Edwards Lifesciences Corporation (EW) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 12,200 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Edwards Lifesciences Leadership Team

John Cardis, Independent Director
Wesley Schack, Presiding Independent Director
Larry Wood, Corporate VP of Transcatheter Heart Valve
Nicholas Valeriani, Director
Leslie Heisz, Director
Catherine Szyman, Corporate Vice President Critical Care
Martha Marsh, Director
Huimin Wang, Corporate Vice President Japan, Asia Pacific
JeanLuc Lemercier, Corporate Vice President EMEA (Europe, Middle East and Africa)
Barbara McNeil, Independent Director
Steven Loranger, Director
William Link, Independent Director
Scott Ullem, CFO and Corporate VP
Patrick Verguet, Corporate VP of EMEA, Canada and Latin America
Kieran Gallahue, Director
Bernard Zovighian, Corporate Vice President -Surgical Heart Valve Therapy
David Erickson, Vice President - Investor Relations
Donald Bobo, Corporate VP of Strategy and Corporate Devel.
Michael Mussallem, Chairman and CEO

Stock Performance Indicators

Current Sentiment - EW

Edwards Lifesciences Investor Sentiment

Larger part of Macroaxis users are currently bullish on Edwards Lifesciences Corporation. What is your opinion about investing in Edwards Lifesciences Corporation? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Edwards Lifesciences Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Edwards Lifesciences and Digirad. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Search macroaxis.com